Amylyx Experimental Drug Avexitide Reduces Severe Hypoglycemia in Phase 3 Trial

By Elaine Chen · STAT News · 2026-08-18

STAT News reports that Amylyx Pharmaceuticals has achieved a significant clinical milestone for its drug avexitide, which targets sudden blood sugar drops following bariatric surgery. The late-stage study results indicate the therapy could become the first approved treatment for

STAT News reports that Amylyx Pharmaceuticals has achieved a significant clinical milestone for its drug avexitide, which targets sudden blood sugar drops following bariatric surgery. The late-stage study results indicate the therapy could become the first approved treatment for